OpenAlex

Metabolic effects and cardiovascular disease risks of TDF or TAF in patients with chronic hepatitis B: a systematic review and meta-analysis

Frontiers in Pharmacology 16 (2025)

Yi Zhou; Nan Cai; Yuxin Chen; Yu‐Chieh Su; Peng Hu

Effects of first-line nucleot(s)ide analogues on lipid profiles in patients with chronic hepatitis B: a network meta-analysis

European Journal of Clinical Pharmacology 80(3) (2024)

Kexin Tong; Mingjing Chen; Danni Wang; Haifeng Dai; Jiayi Peng; Jia Zhang; Jiao Zhou; Yujiao Chang; Wenxiang Huang

Impact of Tenofovir Alafenamide on Lipid Profiles in Chronic Hepatitis B Patients: Systematic Review and Meta‐Analysis

Journal of Medical Virology 97(4) (2025)

Ping‐Yu Hsu; Hui‐Chen Su; Mi-Chia Ma; Chien‐An Chen; Sin‐Yi Yu; Yi‐Ming Hua

Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir

Annals of Hepatology 28(5) (2023)

Fa- Da Wang; Jing Zhou; Lan-Qing Li; Yu-Jing Li; Meng-Lan Wang; Ya-Chao Tao; Dongmei Zhang; Yonghong Wang; En‐Qiang Chen

Tenofovir amibufenamide in chronic hepatitis B: Lipid changes and 144-week safety with tenofovir disoproxil fumarate-to-tenofovir amibufenamide switch

World Journal of Gastroenterology 31(26) (2025)

Zhi-Hao Zeng; Jin-Qing Liu; Min Zhang; Cai-Liang Qiu; Zhenyu Xu

Tenofovir alafenamide versus entecavir in treating patients with chronic hepatitis B: A meta-analysis

Gastroenterología y Hepatología (English Edition) 48(4) (2024)

Jian-Xing Luo; Guo Chen; Xiao-Yu Hu; Chang Chun Yu

Comparative Efficacy and Renal Safety of Entecavir and Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B: A Retrospective Cohort Study From Vietnam

Pharmacology Research & Perspectives 13(5) (2025)

Thong Duy Vo; Han Ngoc Gia Nguyen; Sang The Phan

First year real life experience with tenofovir alafenamide fumarate: The pythagorean cohort

Hepatology forum/Hepatology forum (Online) 4(2) (2023)

Ömer Karaşahin; Irem Akdemir Kalkan; Tuba Dal; Sibel Altunisik Toplu; Murat Harputluoglu; Ayse Ozlem Mete; Suheyla Komur; Figen Sarigul; Yesim Yildiz; Fatih Esmer; Ozlem Kandemir; Selcuk Nazik; Dilara Inan; Fethiye Akgul; Safak Kaya; Nurettin Tunc; Yasar Bayindir; Safak Ozer Balin; Yesim Tasova; Fesih Aktar; Meryem Merve Oner; Merve Ayhan; Yakup Demir; Mustafa Kemal Celen

Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China

Journal of Clinical and Translational Hepatology 000(000) (2026)

Jinlin Hou; Qin Ning; Zhongping Duan; Yu Chen; Qing Xie; Lunli Zhang; Shanming Wu; Hong Tang; Li Jun; Feng Lin; Yongfeng Yang; Guozhong Gong; Yanwen Luo; Yan Chen; Frida Abramov; Leland J. Yee; Hongyuan Wang; Roberto Mateo; Tahmineh Yazdi; Irina Botros; ChengWei Chen; Huang Yan; Mingxiang Zhang; Jidong Jia

Real-life data of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in the patients with chronic hepatitis B: a single-center experience

Anatolian Current Medical Journal 3(3) (2021)

Mustafa Akar

The Effects of the COVID-19 Pandemic on Clinical and Laboratory Follow-up of Patients Diagnosed With Chronic Hepatitis B: A Multicenter, Prospective, Observational Study

Hepatitis Monthly 22(1) (2022)

Fethiye Akgül; Yusuf Arslan; Mehmet Çelik; Ömer Karaşahin; Mustafa Kemal Çelen

Tenofovir-alafenamide

Reactions Weekly 1906(1) (2022)